Luana L S Rodrigues1, Mariza G Morgado2, Vikrant V Sahasrabuddhe3, Vanessa S De Paula4, Nathália S Oliveira5, Elena Chavez-Juan6, Diane M Da Silva7, W Martin Kast8, Alcina F Nicol9, José H Pilotto10. 1. Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro, Brazil; Instituto de Saúde Coletiva, Universidade Federal do Oeste do Pará, Santarém, Pará, Brazil. Electronic address: luana.rodrigues@ufopa.edu.br. 2. Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro, Brazil. Electronic address: mmorgado@ioc.fiocruz.br. 3. Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA. 4. Laboratório de Virologia Molecular, IOC-FIOCRUZ, Rio de Janeiro, Brazil. 5. Programa de Pós-Graduação em Patologia, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil. 6. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. 7. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA; Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA. 8. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA; Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA, USA. 9. Instituto Nacional de Infectologia Evandro Chagas, INI-FIOCRUZ, Rio de Janeiro, Brazil; Laboratório Interdisciplinar de Pesquisas Médicas, IOC-FIOCRUZ, Rio de Janeiro, Brazil. 10. Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro, Brazil.
Abstract
OBJECTIVE: We evaluated acceptability of cervico-vaginal self-collection (CVSC) and prevalence of human papillomavirus (HPV) in Human immunodeficiency virus (HIV)-infected and HIV-uninfected women living in the Tapajós region, Amazon, Brazil. METHODS: Cross-sectional study recruited 153 non-indigenous women (HIV-uninfected, n = 112 and HIV-infected, n = 41) who voluntarily sought assistance in health services. Peripheral blood for HIV screening and cervical scraping (CS) for HPV detection were collected. Women who accepted to perform CVSC received instructions and individual collection kits. Risk factors for high-risk HPV genotypes (hrHPV) were identified by uni- and multivariate analyses. RESULTS: The overall acceptability of CVSC was 87%. Only HIV-infected women had cytological abnormalities (12.2%). Prevalence of any HPV and hrHPV infection was 42.9% and 47.9% for HIV-uninfected and 97.6% and 77.5% for HIV-infected women, respectively. There was significant agreement in the detection of HPV (88%, 0.76, 95% confidence interval [CI], 0.65-0.87) and hrHPV (79.7%, 0.56, 95% CI, 0.41-0.71) between self-collected and clinician-collected samples. The most prevalent hrHPV types were HPV16 and HPV18 in HIV-uninfected and HPV16, HPV51 and HPV59 in HIV-infected women. HIV-infected women with hrHPV infection had multiple hrHPV infections (p = 0.005) and lower CD4 count (p = 0.018). Risk factors for hrHPV infection included being HIV-infected and having five or more sexual partners. CONCLUSIONS: CVSC had high acceptability and high prevalence of hrHPV types in women living in the Tapajós region, Amazon, Brazil.
OBJECTIVE: We evaluated acceptability of cervico-vaginal self-collection (CVSC) and prevalence of humanpapillomavirus (HPV) in Human immunodeficiency virus (HIV)-infected and HIV-uninfectedwomen living in the Tapajós region, Amazon, Brazil. METHODS: Cross-sectional study recruited 153 non-indigenous women (HIV-uninfected, n = 112 and HIV-infected, n = 41) who voluntarily sought assistance in health services. Peripheral blood for HIV screening and cervical scraping (CS) for HPV detection were collected. Women who accepted to perform CVSC received instructions and individual collection kits. Risk factors for high-risk HPV genotypes (hrHPV) were identified by uni- and multivariate analyses. RESULTS: The overall acceptability of CVSC was 87%. Only HIV-infectedwomen had cytological abnormalities (12.2%). Prevalence of any HPV and hrHPV infection was 42.9% and 47.9% for HIV-uninfected and 97.6% and 77.5% for HIV-infectedwomen, respectively. There was significant agreement in the detection of HPV (88%, 0.76, 95% confidence interval [CI], 0.65-0.87) and hrHPV (79.7%, 0.56, 95% CI, 0.41-0.71) between self-collected and clinician-collected samples. The most prevalent hrHPV types were HPV16 and HPV18 in HIV-uninfected and HPV16, HPV51 and HPV59 in HIV-infectedwomen. HIV-infectedwomen with hrHPV infection had multiple hrHPV infections (p = 0.005) and lower CD4 count (p = 0.018). Risk factors for hrHPV infection included being HIV-infected and having five or more sexual partners. CONCLUSIONS: CVSC had high acceptability and high prevalence of hrHPV types in women living in the Tapajós region, Amazon, Brazil.
Authors: A M Cornall; M Poljak; S M Garland; S Phillips; J H Tan; D A Machalek; M A Quinn; S N Tabrizi Journal: Eur J Clin Microbiol Infect Dis Date: 2016-11-08 Impact factor: 3.267
Authors: Thomas C Wright; Mark H Stoler; Catherine M Behrens; Abha Sharma; Guili Zhang; Teresa L Wright Journal: Gynecol Oncol Date: 2015-01-08 Impact factor: 5.482
Authors: R A Hanisch; P S Sow; M Toure; A Dem; B Dembele; P Toure; R L Winer; J P Hughes; G S Gottlieb; Q Feng; N B Kiviat; S E Hawes Journal: J Clin Virol Date: 2013-10-18 Impact factor: 3.168
Authors: Pooja Bansil; Scott Wittet; Jeanette L Lim; Jennifer L Winkler; Proma Paul; Jose Jeronimo Journal: BMC Public Health Date: 2014-06-12 Impact factor: 3.295
Authors: Cynthia Firnhaber; Hoa Van Le; Audrey Pettifor; Doreen Schulze; Pam Michelow; Ian M Sanne; David A Lewis; Anna-Lise Williamson; Bruce Allan; Sophia Williams; Allen Rinas; Simon Levin; Jennifer S Smith Journal: Cancer Causes Control Date: 2009-12-01 Impact factor: 2.506
Authors: Brittney L Dickey; Anna E Coghill; Grant B Ellsworth; Timothy J Wilkin; Luisa L Villa; Anna R Giuliano Journal: Sex Transm Dis Date: 2021-12-01 Impact factor: 2.830
Authors: Luana L S Rodrigues; Justin Hardick; Alcina F Nicol; Mariza G Morgado; Katrini G Martinelli; Vanessa S de Paula; José H Pilotto; Charlotte A Gaydos Journal: PLoS One Date: 2019-04-23 Impact factor: 3.752
Authors: Felipe Ortiz-Gutiérrez; Lilia Sánchez-Minutti; José F Martínez-Herrera; Indiana D Torres-Escobar; Elias B Pezzat-Said; Luis Márquez-Domínguez; Amado I Grandes-Blanco Journal: Pol J Microbiol Date: 2021-12-23